IDSA Summary of recommendations on drugs for use in a treatment regimen for patients with multidrug-resistant tuberculosis, including strength of recommendation, certainty in the evidence, and relative effects on death and treatment success. Strong FOR: • Bedaquiline • Fluoroquinolone: Moxifloxacin, Levofloxacin Conditional FOR: • Linezolid • Clofazimine • Cycloserine • Injectables: Amikacin, Streptomycin • Ethambutol • Pyrazinamide • Injectables: Carbapenems w/ clavulanic acid • Delamanid #MultiDrugResistant #Tuberculosis #MDRTB #management #Treatment #antimicrobials #pharmacology #ebm #idsa
